Subscribe to RSS
DOI: 10.1055/a-2642-8218
Spasms and not Myoclonus in Subacute Sclerosing Panencephalitis. A Case Report and Review of the Literature

Abstract
Subacute sclerosing panencephalitis (SSPE) is a neurodegenerative disease caused by the measles virus. An affected child typically presents with cognitive decline and abnormal movements, described as myoclonia. Early diagnosis is crucial for prognosis, but can be challenging because early symptoms may be subtle, and EEG findings are not always typical. We propose that better description and documentation of motor symptoms may facilitate earlier recognition of SSPE.
A 4-year-old boy presented with cognitive decline and motor symptoms evolving over 6 months. The patient had a history of measles at 2 months of age. Initial investigations, conducted when he developed clinical regression and abnormal movements, were inconclusive. After a partial recovery, he relapsed with further regression, worsening of abnormal movements, and seizures. At our hospital, we diagnosed SSPE based on Dyken's criteria. EEG and EMG recordings showed movements beginning after a diffuse slow wave, followed by a flattening of the EEG line, with a typical diamond pattern on the EMG lasting 0.5 to 1 second. Movements were classified as epileptic spasms.
We propose that patients with SSPE may present epileptic spasms as the abnormal motor phenomena, and not only myoclonus. Raising awareness about epileptic spasms as a clinical manifestation may aid early diagnosis of SSPE.
Keywords
subacute sclerosing panencephalitis - myoclonus - electroclinical presentation - epileptic spasmsPublication History
Received: 24 February 2025
Accepted: 25 June 2025
Article published online:
22 July 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Garg RK, Mahadevan A, Malhotra HS, Rizvi I, Kumar N, Uniyal R. Subacute sclerosing panencephalitis. Rev Med Virol 2019; 29 (05) e2058
- 2 Hayashi M, Arai N, Satoh J. et al. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J Child Neurol 2002; 17 (10) 725-730
- 3 Dyken PR. Subacute sclerosing panencephalitis. Current status. Neurol Clin 1985; 3 (01) 179-196
- 4 Doğulu CF, Ciğer A, Saygi S, Renda Y, Yalaz K. Atypical EEG findings in subacute sclerosing panencephalitis. Clin Electroencephalogr 1995; 26 (04) 193-199
- 5 Hashimoto K, Hosoya M. Advances in antiviral therapy for subacute sclerosing panencephalitis. Molecules 2021; 26 (02) 427
- 6 Eisermann M. Les spasmes épileptiques à début tardif. Epileptologie. 2013; 30: 61-71
- 7 Metz H, Gregoriou M, Sandifer P. Subacute sclerosing pan-encephalitis. A review of 17 cases with special reference to clinical diagnostic criteria. Arch Dis Child 1964; 39 (208) 554-557
- 8 Pampiglione G. Polymyographic studies of some involuntary movements in subacute sclerosing pan-encephalitis. Arch Dis Child 1964; 39 (208) 558-563
- 9 Cobb W. The periodic events of subacute sclerosing leucoencephalitis. Electroencephalogr Clin Neurophysiol 1966; 21 (03) 278-294
- 10 Halliday AM. The electrophysiological study of myoclonus in man. Brain 1967; 90 (02) 241-284
- 11 Garg D, Kakkar V, Kumar A. et al. Spectrum of movement disorders among children with subacute sclerosing panencephalitis: a cross-sectional study. J Child Neurol 2022; 37 (06) 491-496
- 12 Westmoreland BF, Sharbrough FW, Donat JR. Stimulus-induced EEG complexes and motor spasms in subacute sclerosing panencephalitis. Neurology 1979; 29 (08) 1154-1157
- 13 Caraballo RH, Fortini S, Reyes G, Carpio Ruiz A, Sanchez Fuentes SV, Ramos B. Epileptic spasms in clusters and associated syndromes other than West syndrome: a study of 48 patients. Epilepsy Res 2016; 123: 29-35
- 14 Ser MH, Gündüz A, Demirbilek V. et al. Progression of myoclonus subtypes in subacute sclerosing panencephalitis. Neurophysiol Clin 2021; 51 (06) 533-540
- 15 Eisermann M, Fillon L, Saitovitch A. et al. Periodic electroencephalographic discharges and epileptic spasms involve cortico-striatal-thalamic loops on arterial spin labeling magnetic resonance imaging. Brain Commun 2022; 4 (05) fcac250